The CD81 partner EWI-2wint inhibits hepatitis C virus entry.
Two to three percent of the world's population is chronically infected with hepatitis C virus (HCV) and thus at risk of developing liver cancer. Although precise mechanisms regulating HCV entry into hepatic cells are still unknown, several cell surface proteins have been identified as entry fac...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2008-04-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2270906?pdf=render |